Vyome Holdings, Inc. (HIND) Diversifiers

Equity · Currency in USD · Last updated Jun 4, 2026

Vyome Holdings, Inc. is a clinical-stage specialty pharmaceutical company developing therapeutic products for immuno-inflammatory and rare diseases, including treatments for bacterial conjunctivitis, inflammatory acne, and eye inflammation. It also develops antifungal products through its molecular replacement therapy platform and has a collaboration to develop and commercialize next-generation antifungal products.

Looking to balance out your exposure to HIND? The ETFs below have the lowest correlation with HIND — they tend to move on their own, which can help reduce risk when HIND drops. The stock ideas table highlights individual companies that behave independently from HIND.

No Diversifiers Found for HIND

We do not have enough correlation history to rank diversifiers for this symbol yet.

Diversification Analysis

Build a portfolio that complements HIND

Add HIND to the Diversification Analyzer to see how it overlaps with your other holdings and which assets balance it best.

Analyze a portfolio with HIND